CG Oncology, Inc. (CGON)
NASDAQ · Healthcare
CG Oncology, Inc. Net Income 2023–2025
CG Oncology, Inc. annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- CG Oncology, Inc. net income for the quarter ending March 31, 2026 was -60.2 M, a 74.74% increase year-over-year.
- CG Oncology, Inc. net income for the twelve months ending March 31, 2026 was -179.9 M, a 164.51% increase year-over-year.
- CG Oncology, Inc. annual net income for 2025 was -161.0 M, a 82.87% increase from 2024.
- CG Oncology, Inc. annual net income for 2024 was -88.0 M, a 81.12% increase from 2023.
- CG Oncology, Inc. annual net income for 2023 was -48.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
CG Oncology, Inc. Net Income — FAQ
CG Oncology, Inc. (CGON) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is CG Oncology, Inc.'s net income?
CG Oncology, Inc. (CGON) reported net income of -$161M for fiscal 2025.
Where can I see CGON's net income history?
The chart and table above show CG Oncology, Inc.'s net income by year and by quarter, including the growth rate.